UCSF

Goal 3: Shape the future of pharmacy science, policy, education, and patient care by working in fresh and collaborative ways

Mesh scientific and academic disciplines in new ways

Fully integrate engineering into our therapeutics work; participate fully in UCSF's Clinical Translational Science Institute

Milestones

  • Created the UCSF Department of Bioengineering and Therapeutic Sciences, which focuses on speeding the innovation of medicines and medical devices to "intelligent" therapeutics. The new department is a union of the former Department of Biopharmaceutical Sciences in the School of Pharmacy and the Program in Bioengineering in the School of Medicine. It is a joint department between the Schools of Pharmacy and Medicine.
  • Assumed leadership roles in the development of the Center for Translational Science Institute (CTSI) by, for example, co-directing CTSI's new UCSF Strategic Opportunities Support Center to fund and carry forward the translation of research studies into clinical and human studies and eventually into community practice.
  • Created a new associate dean position for external scientific affairs and appointed its first holder. The position is charged with cultivating and moving forward specific, mutually beneficial research partnerships between the School and business entities outside the School, primarily in the pharmaceutical and biotechnology industries.
  • Organized regular meetings between UCSF faculty members and industry scientific leaders of the larger Bay Area biotechnology community. Work has led to numerous university-industry collaborations including those with Johnson and Johnson, Amgen, Genentech, and Bayer.
  • Brought together a venture capital company and several faculty members—a collaboration that led to the founding of the startup company Global Blood Therapeutics, which completed Series A financing and is sponsoring research at UCSF.
  • Sponsored a yearly Bay Area Biotechnology Symposium, during which the program's industry affiliates present their companies' research to a large group of university and public attendees.
  • Led, through the appointment of two consecutive directors, the California Institute of Quantitative Biosciences at UCSF, which aims to apply the quantitative sciences to a better, integrated understanding of biological systems at all levels of complexity.
  • Collaborated with the UCSF School of Medicine and the UC Berkeley Department of Bioengineering in the launch of a Master of Translational Medicine degree program.

Prepare more clinical scientists

Articulate a clear path for PharmD students who wish to pursue research or an academic career; establish a post-PharmD clinical pharmacology and therapeutics research training fellowship program; increase the number of clinical faculty members prepared to do National Institutes of Health-level research

Milestones

  • Hired clinical scientists who can compete for federal funding and serve as faculty mentors for PharmD students.
  • Congratulated clinical faculty members who each received an NIH Clinical Research Career Development Award (K Award): Janel Long-Boyle, PharmD, PhD; Jennifer Cocohoba PharmD; Kirby Lee, PharmD; Kathy Yang, PharmD.
  • Congratulated clinical faculty members who each completed the UCSF Masters Degree Program in Clinical Research: Jennifer Cocohoba, PharmD; Kirby Lee, PharmD; Conan MacDougall, PharmD.
  • Provided the resources to allow clinical faculty members Kathy Yang, PharmD, and Janel Long-Boyle, PharmD, PhD, to receive analytical assistance from the School's Drug Studies Unit for pilot studies, which in turn helped them receive NIH funding.
  • Congratulated clinical faculty member Kathy Yang, PharmD, who received an NIH Research Project Grand Program (R01) award and Janel Long-Boyle, PharmD, PhD, who received an NIH Mentored Career Development (KL2) award.

Advance interprofessional learning and practice among student pharmacists, physicians, nurses, dentists, and physical therapists

Create and support multi-professional teams of faculty members who are dedicated to designing interdisciplinary curricular opportunities among all four professional schools; develop opportunities for peer-to-peer teaching among heath professional students

Milestones

  • Created an associate dean position for teaching and learning and appointed its first holder. The position is charged with promoting contemporary ways of teaching that will both meet the rapidly changing learning needs of PharmD professional students and also maintain the School's national and international leadership role in education. The promotion of interprofessional learning is a key position responsibility.
  • Implemented a California statewide outreach initiative that reaches into the community and provides seniors with one-on-one Medicare Part D counseling. The program served as a model of collaboration among health professionals as student pharmacists taught health professional peers and practitioners about the benefit.
  • Began working aggressively to promote interprofessional education. Participated in the UCSF Center for Innovation in Interprofessional Education, which was launched in January 2012. Joined UCSF's professional programs in a series of defined interprofessional experiences including all first-year learners.
  • Assumed leadership in teaching pharmacology in UCSF's nursing, dental, and physical therapy professional programs.
  • Partnered with the UCSF-affiliated Santa Rosa Family Medicine Residency Program to develop collaborative interprofessional models of care for pharmacy students in North Bay Advanced Pharmacy Practice Experience (APPE) sites in community health centers and community hospitals. Family medicine faculty members have served as preceptors for student pharmacists working with family medicine residents and UCSF medical students.

Prepare our doctor of pharmacy students to be leaders and agents of change

Test and apply new teaching methods; broaden our students' experiences in novel health care practice settings; increase our students' exposure to new ways of thinking, new developments, and new trends; continually assess our curriculum to ensure it is timely, integrated, and relevant.

Milestones

  • Created an associate dean position for accreditation and quality improvement and appointed its first holder. The position is responsible for ensuring that the School continually assesses its PharmD program through the collection and evaluation of specific program data, and by ensuring that any improvements to the program, which might be required by the Accreditation Council for Pharmacy Education (ACPE) as part of the School's accreditation process, are completed and reported back to ACPE.
  • Developed a Programmatic Evaluation Plan for the School (to assess progress related to the School's stated mission) and a PharmD Evaluation Plan for the PharmD curriculum within the School, both of which aim to significantly change the School's approach to assessment.
  • Revised the PharmD educational outcomes-or "terminal competencies"-that describe the abilities of the School's PharmD graduates. This was a significant revision using an evidence-based and best practices approach.
  • Developed milestones for PharmD educational outcomes that will allow the School to track students' achievements of competencies along a gradient as they proceed through the curriculum.
  • Brought E*Value online for its use in the PharmD program. E*Value is a web-based application designed to provide evaluation, analysis, and reporting tools.
  • Led efforts and directly participated in evidence-based revision of assessment-related instruments for the PharmD curriculum (e.g., APPE Student Performance Evaluation form; APPE precepting and course evaluation forms; pathway project student, faculty, and course evaluation forms).
  • Implemented a scientific approach to the collection and analysis of assessment-related data (e.g., significantly changed the Graduating Senior Survey and how results are analyzed annually to highlight significant differences between pathways, APPE sites, and across cohorts of graduates; this approach is currently being translated and implemented with faculty, preceptor, and alumni-related assessment data).
  • Adopted Ilios 2.0, an open-source web application, to collect, manage, analyze, and deliver curricular information via the university's collaborative learning environment. Included all of the required didactic courses in the PharmD program in the system, which maps courses by session to programmatic outcomes as well as to accreditation standards. The program was created through a partnership between the School of Medicine and the Library and is an update of the program created and used by the UCSF SOM since 2002. Our PharmD program became the second UCSF program to use Ilios 2.0.
  • Applied the capture system (MediaSite) to record 19 required courses for the PharmD curriculum. The system records lectures during delivery for playback and review at the student's convenience.
  • Initiated studies to learn more about outcomes associated with the PharmD pathways, which were implemented in 1998. For example, the School completed a study of pathway alumni, 2002-2010.
  • Launched a revamp of the PharmD curriculum.

Strengthen the diversity of our faculty, students, postdoctoral fellows, and staff

Incorporate our commitment to diversity in the School's mission statement; centralize and coordinate the School's diversity agenda; increase the number of faculty, staff, PharmD and PhD students, postdoctoral residents and fellows from historically excluded and currently underrepresented populations

Milestones

  • Reaffirmed among the faculty a shared commitment to diversity and added a statement that captures this commitment to the School's mission statement: We achieve these goals within a culture of understanding, inclusion, equity, and respect. We recruit and support faculty members, staff, and students who are diverse in gender, age, race, ethnicity, religion, sexual orientation, and socioeconomic status. We have a particular commitment to historically excluded populations who are currently underrepresented.
  • Created an associate dean of diversity position and appointed its first holder. The position is charged with establishing and communicating concrete diversity goals for the School; developing and implementing a plan to achieve the School's diversity goals; soliciting input from students, faculty, staff, and alumni through advisory groups or other forums; and coordinating outreach and recruitment initiatives within the School and with other health professional schools and campus units, as appropriate.
  • Implemented a holistic admissions review to ensure the consideration of applicants to the PharmD program includes the sum of their academic strengths, life experience, and potential for leadership in the profession and within underserved communities. This review has netted entering classes that are not only academically strong but also rich in diversity of perspectives, goals, and backgrounds.
  • Improved underrepresented minority (URM) enrollment in the PharmD program.

    Ethnicity 2008 2009 2010 2011 2012

    Blk​/​African American

    0

    3

    3

    5

    9

    Span​/​Hisp​/​Latino

    7

    9

    13

    7

    7

    Filipino

    6

    5

    4

    4

    8

    American Indian

    0

    0

    0

    1

    3

    Total URM

    13

    17

    20

    17

    27

    % of class

    11%

    14%

    16%

    14%

    22%

  • Initiated a post-baccalaureate program, in conjunction with the Schools of Dentistry and Medicine, to provide academic and professional preparation for individuals from diverse backgrounds to support their successful applications to professional schools.
  • Created the Early Conditional Admissions Program (ECAP) to encourage eligible high school students from the California Central Valley to pursue pharmacy careers. ECAP participants are guaranteed early admission to UCSF's PharmD program if they meet certain criteria.

Extend our work globally

Modernize drug development and regulatory processes worldwide through courses that bring together pharmaceutical scientists and policy makers from around the globe; establish opportunities for scientific and academic collaboration with international colleagues; find new therapeutic approaches to treat emerging infectious diseases and common diseases in underdeveloped countries

Milestones

  • Created an associate dean for global affairs position and appointed its first holder. The position is charged with overseeing the School's relationships with the international community and with people and programs at UCSF involved in international work, assessing potential global partnerships and outreach on behalf of the dean, and advising on actions that support the School's mission and strategic plan. The position represents the School's international interests, both at UCSF and abroad.
  • Launched a two-year postgraduate course offered in both Washington, D.C., and San Francisco, CA, to give U.S. industry leaders, regulatory authorities, and universities the scope of knowledge needed to influence significant, broad-reaching improvements in the ways drugs and medical products are developed.
  • Collaborated in the launch of a course in China that ultimately aims to contribute to the improved quality and broader acceptance of Chinese pharmaceuticals and pharmaceutical exports.
  • Congratulated faculty member Lisa Bero, PhD, who was named to represent The Cochrane Collaboration on the World Health Assembly of the World Health Organization (WHO). The Cochrane Collaboration is an international organization that promotes high-quality research and evidenced-based decisions about health care. The seat will allow the Collaboration to have input on the way research evidence is created and used by the WHO.
  • Congratulated faculty member Lisa Bero, PhD, who was named director of the World Health Organization (WHO) Collaborating Center for Pharmaceutical Research and Science Policy. The new center will be based in the Department of Clinical Pharmacy, where Bero is a faculty member and vice chair for research. The center seeks to combine high-quality academic research with WHO's political clout to remove roadblocks that prevent people in lower-income countries from receiving the most crucial and effective medications.
  • Celebrated with faculty member Kathy Giacomini, PhD, as she assumed leadership as the principal investigator of the National Institutes of Health (NIH)-led Global Alliance in Pharmacogenomics, Japan (GAP-J), a large multi-disciplinary collaboration among the Center for Genomic Medicine, RIKEN, Japan, and the NIH Pharmacogenomics Research Network.
  • Increased student participation in global health activities through the development of a structured and coordinated process for these activities, which extends across all three PharmD curriculum pathways. For example, students provided pharmacy leadership and participation in two medical missions to Honduras and participated in international advanced practice pharmacy experiences in Singapore, Taiwan, Japan, Hong Kong, and the People's Republic of China.
  • Established agreements for cooperative education and research between the School and universities in Guatemala, the Philippines, Taiwan, Hong Kong, Singapore, and the People's Republic of China.
  • Faculty member Fran Aweeka, PharmD, worked with Ugandan colleagues in collaborative research in the area of HIV and malaria, in an effort to improve the care of patients with these diseases.
  • Faculty member Sharon Youmans, PharmD, continued a research project in Malawi to study the influence of spiritual leaders in HIV education and control.

Go to: Milestones